Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Anne Stidsholt, Roug"'
Autor:
Sabine Kayser, Khaled Sanber, Giovanni Marconi, Agnese Mattei, Marlise R. Luskin, Amar Kelkar, Marco Cerrano, Daniel Tuyet Kristensen, Anne Stidsholt Roug, Chiara Sartor, Fabio Giglio, Marta Riva, Lorenzo Rizzo, Francesco Saraceni, Selene Guerzoni, Federica Lessi, Erika Borlenghi, Mark J. Levis, Richard F. Schlenk, Tania Jain, Cristina Papayannidis
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
We evaluated response to VEN/HMA in 46 patients with acute myeloid leukemia (AML) characterized by extramedullary disease (EMD). Median age was 65 (range, 19-81) years. Patients had a median of two EMD sites (range, 1-5) and 35 (76%) patients had con
Externí odkaz:
https://doaj.org/article/c5e4bbe9039445ce81f108582a7f9cc3
Autor:
Alexander Schmitz, Rasmus Froberg Brøndum, Hans Erik Johnsen, Ulf-Henrik Mellqvist, Anders Waage, Peter Gimsing, Davine Hofste op Bruinink, Vincent van der Velden, Bronno van der Holt, Markus Hansson, Niels Frost Andersen, Ulf Christian Frølund, Carsten Helleberg, Fredrik H. Schjesvold, Lucia Ahlberg, Nina Gulbrandsen, Bjorn Andreasson, Birgitta Lauri, Einar Haukas, Julie Støve Bødker, Anne Stidsholt Roug, Martin Bøgsted, Marianne T. Severinsen, Henrik Gregersen, Niels Abildgaard, Pieter Sonneveld, Karen Dybkær
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Multiple myeloma remains an incurable disease with multiple relapses due to residual myeloma cells in the bone marrow of patients after therapy. Presence of small number of cancer cells in the body after cancer treatment, called m
Externí odkaz:
https://doaj.org/article/5436faba1b7640768aa73dd91ad91f57
Autor:
Anna A Schönherz, Julie Støve Bødker, Alexander Schmitz, Rasmus Froberg Brøndum, Lasse Hjort Jakobsen, Anne Stidsholt Roug, Marianne T Severinsen, Tarec C El-Galaly, Paw Jensen, Hans Erik Johnsen, Martin Bøgsted, Karen Dybkær
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0229593 (2020)
Acute myeloid leukaemia (AML) is characterised by phenotypic heterogeneity, which we hypothesise is a consequence of deregulated differentiation with transcriptional reminiscence of the normal compartment or cell-of-origin. Here, we propose a classif
Externí odkaz:
https://doaj.org/article/9d6f994c235e49a98003993006237fd0
Autor:
Daniel Tuyet Kristensen, Andreas Kiesbye Øvlisen, Lasse H. Jakobsen, Marianne Tang Severinsen, Louise Hur Hannig, Jørn Starklint, Morten Hagemann Hilsøe, Anders Pommer Vallentin, Mette Brabrand, Hans Carl Hasselbalch, Tarec C. El-Galaly, Anne Stidsholt Roug
Publikováno v:
Kristensen, D T, Øvlisen, A K, Jakobsen, L H, Severinsen, M T, Hannig, L H, Starklint, J, Hilsøe, M H, Vallentin, A P, Brabrand, M, Hasselbalch, H C, El-Galaly, T C & Roug, A S 2023, ' Use of statins and risk of myeloproliferative neoplasms-a Danish nationwide case-control study ', Blood advances . https://doi.org/10.1182/bloodadvances.2023009784
Previous studies have indicated a possible cancer protective effect of statins in solid cancers; however, this has never been investigated for myeloproliferative neoplasms (MPNs). We aimed to investigate the association between statin use and risk of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92d4822709b3ff9d79f993bab49721e6
https://vbn.aau.dk/da/publications/4e982bb8-9728-4fa8-85a9-ec096a63692e
https://vbn.aau.dk/da/publications/4e982bb8-9728-4fa8-85a9-ec096a63692e
Autor:
Daniel Kristensen, Andreas K. Oevlisen, Lasse Hjort Jakobsen, Marianne Tang Severinsen, Tarec Christoffer Christoffer El-Galaly, Anne Stidsholt Roug
Publikováno v:
Kristensen, D, Oevlisen, A K, Jakobsen, L H, Severinsen, M T, El-Galaly, T C C & Roug, A S 2022, ' Statin Use and the Risk of Myeloproliferative Neoplasms in a Population Based Cohort ', Blood, vol. 140, no. Suppl. 1, pp. 6813-6814 . https://doi.org/10.1182/blood-2022-157668
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bc34f9d472bae8d0d8a146b9a8c4dfc
https://vbn.aau.dk/da/publications/900626f3-653a-4420-8658-71f659ea1c83
https://vbn.aau.dk/da/publications/900626f3-653a-4420-8658-71f659ea1c83
Autor:
Andreas K. Oevlisen, Daniel Kristensen, Lasse Hjort Jakobsen, Marianne Tang Severinsen, Tarec Christoffer Christoffer El-Galaly, Anne Stidsholt Roug
Publikováno v:
Oevlisen, A K, Kristensen, D, Jakobsen, L H, Severinsen, M T, El-Galaly, T C C & Roug, A S 2022, ' Metformin Use and the Risk of Myeloproliferative Neoplasms in a Danish Population Based Cohort ', Blood, vol. 140, no. Suppl. 1, pp. 9673-9674 . https://doi.org/10.1182/blood-2022-169947
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50212fbb5a95349fa3313bfcdd2a9f8c
https://vbn.aau.dk/da/publications/d0ffa682-b6f9-4454-904b-20091df8447a
https://vbn.aau.dk/da/publications/d0ffa682-b6f9-4454-904b-20091df8447a
Autor:
Daniel Tuyet Kristensen, Lars Børty Nielsen, Lasse Hjort Kyneb Jakobsen, Tove‐Christina Choe Kristensen, Lene Østergaard Jepsen, Claudia Schöllkopf, Kim Theilgaard‐Mönch, Tarec Christoffer El‐Galaly, Anne Stidsholt Roug, Marianne Tang Severinsen
Publikováno v:
Kristensen, D T, Nielsen, L B, Jakobsen, L H K, Kristensen, T-C C, Jepsen, L Ø, Schöllkopf, C, Theilgaard-Mönch, K, El-Galaly, T C, Roug, A S & Severinsen, M T 2022, ' Effects of chemotherapy dose reductions in overweight patients with acute myeloid leukaemia : A Danish nationwide cohort study ', British Journal of Haematology, vol. 199, no. 4, pp. 539-548 . https://doi.org/10.1111/bjh.18448
Kristensen, D T, Nielsen, L B, Jakobsen, L H K, Kristensen, T C C, Jepsen, L Ø, Schöllkopf, C, Theilgaard-Mönch, K, El-Galaly, T C, Roug, A S & Severinsen, M T 2022, ' Effects of chemotherapy dose reductions in overweight patients with acute myeloid leukaemia : A Danish nationwide cohort study ', British Journal of Haematology, vol. 199, no. 4, pp. 539-548 . https://doi.org/10.1111/bjh.18448
Kristensen, D T, Nielsen, L B, Jakobsen, L H K, Kristensen, T-C C, Jepsen, L Ø, Schöllkopf, C, Theilgaard-Mönch, K, El-Galaly, T C, Roug, A S & Severinsen, M T 2022, ' Effects of chemotherapy dose reductions in overweight patients with acute myeloid leukaemia : A Danish nationwide cohort study ', British Journal of Haematology, vol. 199, pp. 539-548 . https://doi.org/10.1111/bjh.18448
Kristensen, D T, Nielsen, L B, Jakobsen, L H K, Kristensen, T C C, Jepsen, L Ø, Schöllkopf, C, Theilgaard-Mönch, K, El-Galaly, T C, Roug, A S & Severinsen, M T 2022, ' Effects of chemotherapy dose reductions in overweight patients with acute myeloid leukaemia : A Danish nationwide cohort study ', British Journal of Haematology, vol. 199, no. 4, pp. 539-548 . https://doi.org/10.1111/bjh.18448
Kristensen, D T, Nielsen, L B, Jakobsen, L H K, Kristensen, T-C C, Jepsen, L Ø, Schöllkopf, C, Theilgaard-Mönch, K, El-Galaly, T C, Roug, A S & Severinsen, M T 2022, ' Effects of chemotherapy dose reductions in overweight patients with acute myeloid leukaemia : A Danish nationwide cohort study ', British Journal of Haematology, vol. 199, pp. 539-548 . https://doi.org/10.1111/bjh.18448
Overweight patients with cancer are frequently reduced in chemotherapy dose due to toxicity concerns, although previous studies have indicated that dose reduction (DR) of overweight patients results in comparable toxicity but may compromise overall s
Autor:
Charles Vesteghem, Simon Christian Dahl, Rasmus Froberg Brøndum, Mads Sønderkær, Julie Støve Bødker, Alexander Schmitz, Joachim Weischenfeldt, Inge Søkilde Pedersen, Mia Sommer, Anne Stoffersen Rytter, Marlene Maria Nielsen, Morten Ladekarl, Marianne Tang Severinsen, Karen Dybkær, Kirsten Grønbæk, Tarec El-Galaly, Anne Stidsholt Roug, Martin Bøgsted
ObjectivesTo facilitate clinical implementation and research in precision oncology, notably the pairing of patients, variants and treatments to identify candidates for clinical trials, we have built a data infrastructure to 1) capture and store data,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d974240ed948f3717ea6044938dc84fd
https://doi.org/10.1101/2022.05.09.22274599
https://doi.org/10.1101/2022.05.09.22274599
Autor:
Daniel A. Arber, Robert P. Hasserjian, Attilio Orazi, Vikram Mathews, Andrew W. Roberts, Charles A. Schiffer, Anne Stidsholt Roug, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi
Publikováno v:
Arber, D A, Hasserjian, R P, Orazi, A, Mathews, V, Roberts, A W, Schiffer, C A, Roug, A S, Cazzola, M, Döhner, H & Tefferi, A 2022, ' Classification of myeloid neoplasms/acute leukemia : Global perspectives and the international consensus classification approach ', American Journal of Hematology, vol. 97, no. 5, pp. 514-518 . https://doi.org/10.1002/ajh.26503
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbe8fa3cb2866d1d1943d9403f4da150
https://pure.au.dk/portal/da/publications/classification-of-myeloid-neoplasmsacute-leukemia(1a4900fa-b2a0-43a4-b7a9-9d9a4d3663ba).html
https://pure.au.dk/portal/da/publications/classification-of-myeloid-neoplasmsacute-leukemia(1a4900fa-b2a0-43a4-b7a9-9d9a4d3663ba).html
Autor:
Marie Toft-Petersen, Eigil Kjeldsen, Line Nederby, Kirsten Grønbæk, Peter Hokland, Anne Stidsholt Roug
Publikováno v:
Leukemia Research Reports, Vol 3, Iss 2, Pp 94-97 (2014)
We have identified a novel 7.7 Mb del(8)(q23.2q24.11) in a patient progressing to acute myeloid leukemia (AML) following a 12-year stable phase of chronic myelomonocytic leukemia (CMML). A surprisingly high JAK2+ allelic burden of 92% at the time of
Externí odkaz:
https://doaj.org/article/c0ec27d5b21b40368f542913338e27fa